Pulmonary Thromboembolism Clinical Trial
Official title:
Incidence of Thromboembolic Events and Prognosis of COVID-19 Patients Hospitalized in Intensive Care Units in France
The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01580085 -
Obstructive Sleep Apnea in Pulmonary Embolism
|
N/A | |
Enrolling by invitation |
NCT01558206 -
Ultrasonography of Chest Versus Pulmonary Artery CT Angiography in Patients With Symptoms and Signs in Favor of PTE
|
N/A | |
Completed |
NCT01513759 -
Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy
|
Phase 3 | |
Completed |
NCT02616991 -
Computed Tomography CT Venography During Postpartum Venous Thromboembolism
|
N/A | |
Completed |
NCT00968929 -
Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)
|
Phase 4 | |
Not yet recruiting |
NCT06206967 -
Promotion of Active Lifestyle in Thromboembolism Patients
|
N/A | |
Completed |
NCT03595891 -
The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung
|
||
Completed |
NCT01206751 -
Multi-detector Computer Tomography Protocol Project: Chest Imaging Technique and Case Presentation
|
N/A |